Article
Genomic alterations in hepatocellular carcinoma patients undergoing liver transplantation predict recurrence and prognosis
2024-02-16
Abstract excerpt
<title>Abstract</title> <p>Liver transplantation (LT) stands as a pivotal treatment for hepatocellular carcinoma (HCC), outperforming comprehensive treatments in long-term efficacy. However, the 5-year post-LT survival rate hovers between 60% and 70%, largely due to recurrent HCC, spotlighting the critical need for biomarkers that can predict recurrence and prognosis following LT. Our study embarked on this chall...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1163dfe3-5707-58a7-87a8-d32d2f5f2412
- DOI
- 10.21203/rs.3.rs-3928472/v1
